SAN ANTONIO--(EON: Enhanced Online News)--The Association of Clinical Pharmacology Units (ACPU), the home for the Clinical Pharmacology Unit community, announces the release of the final program for their upcoming annual meeting.
“This year we have a truly outstanding program, focused on Quality in Phase I and featuring a variety of engaging sessions with the leaders of the Phase I industry”
The ACPU annual meeting will take place at the Marriott Courtyard hotel, located along the historic River Walk in San Antonio, Texas, on October 21st-23rd. Featured speakers include Dr. Greg Koski, MD, PhD, of the Harvard Medical School and CEO of the Alliance for Clinical Research Excellence and Safety (ACRES); Dr. Marjorie A. Speers, PhD, President and CEO, AAHRPP; and Dr. Tony Tolcher, MD, Director of Clinical Research at South Texas Accelerated Research Therapeutics (START).
“This year we have a truly outstanding program, focused on Quality in Phase I and featuring a variety of engaging sessions with the leaders of the Phase I industry,” said Donna Dorozinsky, ACPU President. “I believe both Phase I focused PIs and CPU Operational managers will be impressed with the exceptional quality of the training and information incorporated into this year’s program.”
The opportunity to tour a state-of-the-art Clinical Pharmacology Unit is always a big draw at ACPU’s annual meeting. This year, the San Antonio clinics of World Wide Clinical Trials and the Texas Liver Institute will be open for attendees.
ACPU is the home for the Clinical Pharmacology Unit community. ACPU members are a community of Clinical Pharmacology Units, their staff, and CPU support professionals. While other groups address the science of early phase studies, ACPU is the only organization that provides support for CPUs and staff to meet the significant operational challenges of early phase study conduct. For more information, visit www.acpu.net.